India Education Diary on MSN
HKUMed develops novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...
The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...
As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...
The United States completed its withdrawal from the World Health Organization due to the group’s mishandling of the COVID-19 pandemic, with a medical group praising the ...
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated ...
The cb1 vaccine platform demonstrates a single, intranasally administered vaccine can confer wide-ranging immunity that may ...
ETHealthworld.com brings latest dr harsh vardhan news, views and updates from all top sources for the Indian Health industry.
This document repository is meant to serve as the start of a crowd-sourced collection of information, documentation, protocols and other resources for public health laboratories intending to sequence ...
ABSTRACT: Genomic surveillance has proven to be a critical source of information for understanding and responding to the COVID-19 pandemic. In Africa, genomic surveillance was very limited, and few ...
Sarbecoviruses, such as SARS-CoV-2, utilize angiotensin-converting enzyme 2 (ACE2) as the entry receptor; while merbecoviruses, such as MERS-CoV, use dipeptidyl peptidase 4 (DPP4) for viral entry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results